SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001372514-24-000030
Filing Date
2024-03-25
Accepted
2024-03-25 16:32:27
Documents
5
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A kiora-definitiveproxyxannu.htm DEF 14A 957330
2 COMPENSATION ACTUALLY PAID AND CUMMULATVE TSR chart-cab74e4eb1344984b6f.jpg GRAPHIC 104526
3 KIORA LOGO kioralogo.jpg GRAPHIC 36955
4 PROXYCARD1 proxy1.jpg GRAPHIC 154847
5 PROXYCARD2 proxy2.jpg GRAPHIC 92730
  Complete submission text file 0001372514-24-000030.txt   1494876
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36672 | Film No.: 24779683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)